1-15 of 15
Scott J. Jacober
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects

Robert R. Henry, Sunder Mudaliar, Theodore P. Ciaraldi, Debra A. Armstrong, Paivi Burke, Jeremy Pettus, Parag Garhyan, Siak Leng Choi, Scott J. Jacober, Mary Pat Knadler, Eric Chen Quin Lam, Melvin J. Prince, Namrata Bose, Niels Porksen, Vikram P. Sinha, Helle Linnebjerg
Journal: Diabetes Care
Diabetes Care 2014;37(9):2609–2615
https://doi.org/10.2337/dc14-0210
Published: 07 August 2014
View article titled, Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects
Open the PDF for Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects in another window
Includes: Supplementary data
Journal Articles

Lower Glucose Variability and Hypoglycemia Measured by Continuous Glucose Monitoring With Novel Long-Acting Insulin LY2605541 Versus Insulin Glargine

Richard M. Bergenstal, Julio Rosenstock, Edward J. Bastyr, III, Melvin J. Prince, Yongming Qu, Scott J. Jacober
Journal: Diabetes Care
Diabetes Care 2014;37(3):659–665
https://doi.org/10.2337/dc12-2621
Published: 11 February 2014
View article titled, Lower Glucose Variability and Hypoglycemia Measured by Continuous Glucose Monitoring With Novel Long-Acting Insulin LY2605541 Versus Insulin Glargine
Open the PDF for Lower Glucose Variability and Hypoglycemia Measured by Continuous Glucose Monitoring With Novel Long-Acting Insulin LY2605541 Versus Insulin Glargine in another window
Journal Articles

Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147

Richard M. Bergenstal, MD, Julio Rosenstock, MD, Richard F. Arakaki, MD, Melvin J. Prince, MD, Yongming Qu, PHD, Vikram P. Sinha, PHD, Daniel C. Howey, MD, Scott J. Jacober, DO
Journal: Diabetes Care
Diabetes Care 2013;36(7):e107–e108
https://doi.org/10.2337/dc13-0295
Published: 12 June 2013
View article titled, Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147
Open the PDF for Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 in another window
Journal Articles

Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: A randomized, crossover study

Julio Rosenstock, MD, Richard M. Bergenstal, MD, Thomas C. Blevins, MD, Linda A. Morrow, MD, Melvin J. Prince, MD, Yongming Qu, PHD, Vikram P. Sinha, PHD, Daniel C. Howey, MD, Scott J. Jacober, DO
Journal: Diabetes Care
Diabetes Care 2013;36(3):522–528
https://doi.org/10.2337/dc12-0067
Published: 13 February 2013
View article titled, Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: <subtitle>A randomized, crossover study</subtitle>
Open the PDF for Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: <subtitle>A randomized, crossover study</subtitle> in another window
Includes: Supplementary data
Journal Articles

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes

Richard M. Bergenstal, MD, Julio Rosenstock, MD, Richard F. Arakaki, MD, Melvin J. Prince, MD, Yongming Qu, PHD, Vikram P. Sinha, PHD, Daniel C. Howey, MD, Scott J. Jacober, DO
Journal: Diabetes Care
Diabetes Care 2012;35(11):2140–2147
https://doi.org/10.2337/dc12-0060
Published: 13 October 2012
View article titled, A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes
Open the PDF for A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Post Hoc Subgroup Analysis of the HEART2D Trial Demonstrates Lower Cardiovascular Risk in Older Patients Targeting Postprandial Versus Fasting/Premeal Glycemia

Itamar Raz, MD, Antonio Ceriello, MD, Peter W. Wilson, MD, Chakib Battioui, PHD, Eric W. Su, PHD, Lisa Kerr, MSPH, Cate A. Jones, PHD, Zvonko Milicevic, MD, Scott J. Jacober, DO
Journal: Diabetes Care
Diabetes Care 2011;34(7):1511–1513
https://doi.org/10.2337/dc10-2375
Published: 17 June 2011
View article titled, Post Hoc Subgroup Analysis of the HEART2D Trial Demonstrates Lower Cardiovascular Risk in Older Patients Targeting Postprandial Versus Fasting/Premeal Glycemia
Open the PDF for Post Hoc Subgroup Analysis of the HEART2D Trial Demonstrates Lower Cardiovascular Risk in Older Patients Targeting Postprandial Versus Fasting/Premeal Glycemia in another window
Journal Articles

A Decrease in Glucose Variability Does Not Reduce Cardiovascular Event Rates in Type 2 Diabetic Patients After Acute Myocardial Infarction: A reanalysis of the HEART2D study

Sarah E. Siegelaar, MD, Lisa Kerr, MSPH, Scott J. Jacober, DO, J. Hans Devries, MD
Journal: Diabetes Care
Diabetes Care 2011;34(4):855–857
https://doi.org/10.2337/dc10-1684
Published: 21 March 2011
View article titled, A Decrease in Glucose Variability Does Not Reduce Cardiovascular Event Rates in Type 2 Diabetic Patients After Acute Myocardial Infarction: <subtitle>A reanalysis of the HEART2D study</subtitle>
Open the PDF for A Decrease in Glucose Variability Does Not Reduce Cardiovascular Event Rates in Type 2 Diabetic Patients After Acute Myocardial Infarction: <subtitle>A reanalysis of the HEART2D study</subtitle> in another window
Journal Articles

Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial

Itamar Raz, MD, Peter W.F. Wilson, MD, Krzysztof Strojek, MD, PHD, Irina Kowalska, MD, Velimir Bozikov, MD, PHD, Anselm K. Gitt, MD, György Jermendy, MD, Barbara N. Campaigne, PHD, Lisa Kerr, MSPH, Zvonko Milicevic, MD, Scott J. Jacober, DO
Journal: Diabetes Care
Diabetes Care 2009;32(3):381–386
https://doi.org/10.2337/dc08-1671
Published: 01 March 2009
View article titled, Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial
Open the PDF for Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial in another window
Includes: Supplementary data
Journal Articles

Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia

Mark A. Deeg, MD, John B. Buse, MD, Ronald B. Goldberg, MD, David M. Kendall, MD, Anthony J. Zagar, MS, Scott J. Jacober, DO, Mehmood A. Khan, MD, Alfonzo T. Perez, MD, Meng H. Tan, MD, on behalf of the GLAI Study Investigators
Journal: Diabetes Care
Diabetes Care 2007;30(10):2458–2464
https://doi.org/10.2337/dc06-1903
Published: 01 October 2007
View article titled, Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia
Open the PDF for Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia in another window
Journal Articles

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia: Response to Bell and Brunzell

Ronald B. Goldberg, MD, David M. Kendall, MD, Mark A. Deeg, MD, PHD, John B. Buse, MD, PHD, Anthony J. Zagar, MS, Jane A. Pinaire, PHD, Meng H. Tan, MD, Mehmood A. Khan, MD, Alfonso T. Perez, MD, Scott J. Jacober, DO, for the GLAI Study Investigators
Journal: Diabetes Care
Diabetes Care 2005;28(12):2985–2986
https://doi.org/10.2337/diacare.28.12.2985
Published: 01 December 2005
View article titled, A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia: <subtitle>Response to Bell and Brunzell</subtitle>
Open the PDF for A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia: <subtitle>Response to Bell and Brunzell</subtitle> in another window
Journal Articles

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Ronald B. Goldberg, MD, David M. Kendall, MD, Mark A. Deeg, MD, PHD, John B. Buse, MD, PHD, Anthony J. Zagar, MS, Jane A. Pinaire, PHD, Meng H. Tan, MD, Mehmood A. Khan, MD, Alfonso T. Perez, MD, Scott J. Jacober, DO, for the GLAI Study Investigators
Journal: Diabetes Care
Diabetes Care 2005;28(7):1547–1554
https://doi.org/10.2337/diacare.28.7.1547
Published: 01 July 2005
View article titled, A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Open the PDF for A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia in another window
Journal Articles

Control of Cardiovascular Risk Factors in Patients With Diabetes and Hypertension at Urban Academic Medical Centers

Samy I. McFarlane, MD, Scott J. Jacober, DO, Nathaniel Winer, MD, Jasjeet Kaur, MD, Jonathan P. Castro, MD, MaryLou A. Wui, MD, Agnes Gliwa, MD, Hans Von Gizycki, James R. Sowers, MD
Journal: Diabetes Care
Diabetes Care 2002;25(4):718–723
https://doi.org/10.2337/diacare.25.4.718
Published: 01 April 2002
View article titled, Control of Cardiovascular Risk Factors in Patients With Diabetes and Hypertension at Urban Academic Medical Centers
Open the PDF for Control of Cardiovascular Risk Factors in Patients With Diabetes and Hypertension at Urban Academic Medical Centers in another window
Journal Articles

The Safety of Injecting Insulin Through Clothing

Doris R Fleming, MSN, RN, CS, CDE, Scott J Jacober, DO, CDE, Melissa A Vandenberg, BSN, RN, CDE, James T Fitzgerald, PHD, George Grunberger, MD
Journal: Diabetes Care
Diabetes Care 1997;20(3):244–247
https://doi.org/10.2337/diacare.20.3.244
Published: 01 March 1997
View article titled, The Safety of Injecting Insulin Through Clothing
Open the PDF for The Safety of Injecting Insulin Through Clothing in another window
Journal Articles

Diabetes and Pregnancy: Factors associated with seeking pre-conception care

Nancy K Janz, PHD, William H Herman, MD, Mark P Becker, PHD, Denise Charron-Prochownik, PHD, Viktoria L Shayna, MS, Timothy G Lesnick, MS, Scott J Jacober, DO, J David Fachnie, MD, Davida F Kruger, MSN, Jeffrey A Sanfield, MD, Solomon I Rosenblatt, MD, Robert P Lorenz, MD
Journal: Diabetes Care
Diabetes Care 1995;18(2):157–165
https://doi.org/10.2337/diacare.18.2.157
Published: 01 February 1995
View article titled, Diabetes and Pregnancy: Factors associated with seeking pre-conception care
Open the PDF for Diabetes and Pregnancy: Factors associated with seeking pre-conception care in another window
Journal Articles

A Prospective Study Identifying Risk Factors for Discontinuance of Insulin Pump Therapy

John C Floyd, Jr, MD, Richard G Cornell, PHD, Scott J Jacober, DO, Lauren E Griffith, MS, Martha M Funnell, MS, RN, Leora L Wolf, BS, Fredric M Wolf, PHD
Journal: Diabetes Care
Diabetes Care 1993;16(11):1470–1478
https://doi.org/10.2337/diacare.16.11.1470
Published: 01 November 1993
View article titled, A Prospective Study Identifying Risk Factors for Discontinuance of Insulin Pump Therapy
Open the PDF for A Prospective Study Identifying Risk Factors for Discontinuance of Insulin Pump Therapy in another window